Furthermore, CB1 agonists are putative anticonvulsant drugs as described by Ghanbari et al. (2020), which reported that the adminstration of arachidonyl-2'-chloroethylamide (ACEA) inhibited the proconvulsant effect of toxoplasmosis in mice (19). Here, CNR1 is linked to toxoplasmosis.